IP Library Granted Patent US 7,651,527
Granted Patent B2
US 7,651,527 · App. 11/611,533 · Granted Jan 26, 2010

Bioresorbable stent

Assignee: Medtronic Vascular, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,651,527
App. No.
11/611,533
Granted
Jan 26, 2010
Kind
B2
Abstract

A bioresorbable endoluminal prosthesis for placement in a body lumen having a stent substrate of a first metallic material that has a lower electrical potential than a standard reference electrode. The stent substrate is coated with a biodegradable polymer having a second metallic material dispersed therein, wherein the second metallic material has a higher electrical potential than the standard reference electrode. After implantation of the stent within the body lumen, the second metallic material is present in the polymeric coating in a sufficient concentration to cause galvanic corrosion of the first metallic material such that over time the stent substrate is bioresorbed.

Claims (14)

1. An endoluminal prosthesis for placement in a body lumen comprising:

a stent substrate comprised of a first metallic material that has a lower electrical potential than a standard reference electrode; and

a biocompatible coating disposed on the stent substrate, the coating being comprised of a biodegradable polymer having a second metallic material dispersed therein, wherein the second metallic material has a higher electrical potential than the standard reference electrode and is present in the coating in a sufficient particulate density to cause galvanic corrosion of the first metallic material after placement of the endoluminal prosthesis within the body lumen.

2. The endoluminal prosthesis of claim 1 , wherein the standard reference electrode is one of a standard hydrogen electrode and a saturated calomel electrode.

3. The endoluminal prosthesis of claim 2 , wherein the first metallic material is selected from a group consisting of magnesium, zinc, aluminum, stainless steel, nickel, and manganese, and alloys thereof.

4. The endoluminal prosthesis of claim 3 , wherein the second metallic material is selected from a group consisting of platinum, gold, titanium, silver, tantalum, and iridium, and alloys thereof.

5. The endoluminal prosthesis of claim 4 , wherein the second metallic material is dispersed within the coating as a powder.

6. The endoluminal prosthesis of claim 2 , wherein the electrical potential of the first metallic material is in the range of −0.1 to −2.0 volts with respect to the saturated calomel electrode.

7. The endoluminal prosthesis of claim 6 , wherein the electrical potential of the second metallic material is in the range of 1.0 to 3.0 volts with respect to the saturated calomel electrode.

8. The endoluminal prosthesis of claim 7 , wherein the second metallic material is dispersed within the coating as a powder.

9. The endoluminal prosthesis of claim 1 , wherein the stent substrate is bioresorbed due to the galvanic corrosion.

10. The endoluminal prosthesis of claim 9 , wherein the stent substrate is fully bioresorbed prior to complete degradation of the biodegradable polymer coating.

11. The endoluminal prosthesis of claim 9 , wherein the biodegradable polymer coating is completely degraded prior to the stent substrate being fully bioresorbed.

12. The endoluminal prosthesis of claim 1 , wherein galvanic corrosion of the stent substrate begins a therapeutically appropriate period of time after placement of the prosthesis within the body lumen.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2006
From: KRIVORUCHKO, MICHAEL; ALLEN, JEFFREY; BIRDSALL, MATTHEW
To: MEDTRONIC VASCULAR, INC.
Reel/Frame 018641/0797 →
Continuity (1)
Related Publication 20080147175A1 · Jun 19, 2008